Regulators Call for More Harmonization On Ultra-Rare ATMPs
Executive Summary
Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.
You may also be interested in...
Can The UK Remain A First Launch Market?
More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.
Gilead’s Trodelvy To Test UK Innovative Drug Pathway
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.
EU Council Agrees Compromise Position On Joint Clinical Assessments
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.